Your browser doesn't support javascript.
loading
N-glycosylation on Asn-57 is required for the correct HAI-2 protein folding and protease inhibitory activity.
Huang, Nanxi; Wang, Qiaochu; Chen, Chao-Yang; Hu, Je-Ming; Wang, Jehng-Kang; Chang, Ping-Ying; Johnson, Michael D; Lin, Chen-Yong.
Afiliação
  • Huang N; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, United States.
  • Wang Q; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, United States.
  • Chen CY; School of Medicine, National Defense Medical Center, Taipei 114, Taiwan, ROC.
  • Hu JM; Division of Colorectal Surgery, Department of Surgery, Tri-Service General Hospital, Taipei 114, Taiwan, ROC.
  • Wang JK; School of Medicine, National Defense Medical Center, Taipei 114, Taiwan, ROC.
  • Chang PY; Division of Colorectal Surgery, Department of Surgery, Tri-Service General Hospital, Taipei 114, Taiwan, ROC.
  • Johnson MD; Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 114, Taiwan, ROC.
  • Lin CY; Department of Biochemistry, National Defense Medical Center, Taipei 114, Taiwan, ROC.
Glycobiology ; 33(3): 203-214, 2023 04 19.
Article em En | MEDLINE | ID: mdl-36637420
ABSTRACT
Hepatocyte growth factor activator inhibitor (HAI)-2 is an integral membrane Kunitz-type serine protease inhibitor that regulates the proteolysis of matriptase and prostasin in a cell-type selective manner. The cell-type selective nature of HAI-2 function depends largely on whether the inhibitor and potential target enzymes are targeted to locations in close proximity. The N-glycan moiety of HAI-2 can function as a subcellular targeting signal. HAI-2 is synthesized with 1 of 2 different N-glycan modifications one of oligomannose-type, which largely remains in the endoplasmic reticulum/GA, and another of complex-type, which is targeted toward the apical surface in vesicle-like structures, and could function as an inhibitor of matriptase and prostasin. HAI-2 contains 2 putative N-glycosylation sites, Asn-57 and Asn-94, point mutations of which were generated and characterized in this study. The protein expression profile of the HAI-2 mutants indicates that Asn-57, and not Asn-94, is responsible for the N-glycosylation of both HAI-2 species, suggesting that the form with oligomannose-type N-glycan is the precursor of the form with complex-type N-glycan. Unexpectedly, the vast majority of non-glycosylated HAI-2 is synthesized into multiple disulfide-linked oligomers, which lack protease inhibitory function, likely due to distorted conformations caused by the disarrayed disulfide linkages. Although forced expression of HAI-2 in HAI-2 knockout cells artificially enhances HAI-2 oligomerization, disulfide-linked HAI-2 oligomers can also be observed in unmodified cells. These results suggest that N-glycosylation on Asn-57 is required for folding into a functional HAI-2 with full protease suppressive activity and correct subcellular targeting signal.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteínas de Membrana / Retículo Endoplasmático Idioma: En Revista: Glycobiology Assunto da revista: BIOQUIMICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteínas de Membrana / Retículo Endoplasmático Idioma: En Revista: Glycobiology Assunto da revista: BIOQUIMICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos